Black Swan Sale

50% Off Elite

Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Last Close
Nov 26  •  04:00PM ET
2.42
Dollar change
+0.01
Percentage change
0.62
%
Index- P/E- EPS (ttm)-0.58 Insider Own0.54% Shs Outstand37.39M Perf Week8.74%
Market Cap90.67M Forward P/E- EPS next Y-0.68 Insider Trans0.00% Shs Float37.19M Perf Month33.98%
Enterprise Value87.12M PEG- EPS next Q-0.14 Inst Own36.74% Short Float0.09% Perf Quarter33.24%
Income-21.73M P/S1.29 EPS this Y-14.58% Inst Trans-1.95% Short Ratio0.37 Perf Half Y35.47%
Sales70.36M P/B3.31 EPS next Y-0.76% ROA- Short Interest0.03M Perf YTD9.73%
Book/sh0.73 P/C7.30 EPS next 5Y2.29% ROE- 52W High3.05 -20.47% Perf Year-1.82%
Cash/sh0.33 P/FCF- EPS past 3/5Y- - ROIC-71.60% 52W Low1.21 100.41% Perf 3Y-76.79%
Dividend Est.- EV/EBITDA- Sales past 3/5Y10.02% 6.65% Gross Margin43.23% Volatility7.96% 8.76% Perf 5Y-41.28%
Dividend TTM- EV/Sales1.24 EPS Y/Y TTM-1.33% Oper. Margin-32.12% ATR (14)0.19 Perf 10Y-56.38%
Dividend Ex-Date- Quick Ratio0.97 Sales Y/Y TTM- Profit Margin-30.88% RSI (14)60.21 Recom2.33
Dividend Gr. 3/5Y- - Current Ratio1.41 EPS Q/Q11.78% SMA2013.12% Beta-0.16 Target Price5.86
Payout- Debt/Eq0.32 Sales Q/Q-4.60% SMA507.90% Rel Volume0.18 Prev Close2.41
Employees310 LT Debt/Eq0.11 EarningsNov 06 BMO SMA20021.81% Avg Volume92.36K Price2.42
IPOAug 01, 1997 Option/ShortYes / Yes EPS/Sales Surpr.40.76% 6.26% Trades Volume16,732 Change0.62%
Date Action Analyst Rating Change Price Target Change
May-15-25Downgrade Piper Sandler Overweight → Neutral
Apr-04-25Downgrade Jefferies Buy → Hold $2
Nov-01-22Initiated Jefferies Buy $11
Apr-28-21Initiated Piper Sandler Overweight $13
Apr-15-20Initiated B. Riley FBR Buy $5.50
Jul-28-14Downgrade Northland Capital Outperform → Market Perform $6 → $3.50
Jun-16-14Initiated H.C. Wainwright Buy $6
Mar-05-13Initiated Northland Capital Outperform $6
Nov-18-10Reiterated Morgan Joseph Buy $3 → $5.25
Aug-20-09Reiterated Roth Capital Hold $2.50 → $5
Nov-20-25 07:30AM
Nov-18-25 07:00AM
Nov-06-25 04:00PM
07:30AM
Nov-04-25 07:00AM
07:00AM Loading…
Oct-27-25 07:00AM
Oct-23-25 07:00AM
Oct-20-25 08:30AM
Oct-17-25 09:50AM
Sep-30-25 07:00AM
Sep-16-25 07:00AM
Sep-08-25 07:00AM
Aug-28-25 07:00AM
Aug-27-25 09:29AM
Aug-26-25 07:00AM
07:00AM Loading…
Aug-25-25 07:00AM
Aug-07-25 07:00AM
Jul-04-25 04:19AM
Jul-01-25 07:00AM
May-27-25 07:00AM
May-16-25 03:09AM
May-15-25 07:00AM
May-14-25 09:56AM
May-01-25 07:00AM
Apr-30-25 09:01AM
Apr-29-25 09:05AM
07:00AM
Apr-28-25 01:19PM
Apr-24-25 07:00AM
Apr-22-25 07:00AM
03:01AM Loading…
Mar-28-25 03:01AM
Mar-27-25 11:56AM
07:10AM
Mar-06-25 07:00AM
Mar-03-25 07:00AM
Feb-06-25 08:00AM
Jan-13-25 07:00AM
Jan-10-25 07:00AM
Jan-08-25 07:00AM
Dec-04-24 09:10AM
Dec-02-24 07:00AM
Nov-27-24 07:00AM
Nov-22-24 08:00AM
Nov-19-24 08:00AM
Nov-08-24 06:02AM
Nov-07-24 07:00AM
Nov-06-24 08:00AM
07:50AM
Oct-30-24 01:01AM
Oct-24-24 08:00AM
Oct-01-24 07:00AM
Sep-19-24 08:00AM
Aug-29-24 08:00AM
Aug-28-24 07:00AM
Aug-07-24 07:00AM
Aug-06-24 07:00AM
Jul-22-24 06:33AM
Jul-19-24 04:15PM
Jul-08-24 07:00AM
Jun-03-24 08:00AM
May-22-24 08:00AM
May-17-24 08:10AM
May-16-24 12:52PM
08:00AM
May-06-24 08:00AM
May-02-24 08:00AM
Apr-23-24 08:00AM
Mar-29-24 09:44AM
Mar-27-24 11:53AM
07:00AM
Mar-13-24 07:00AM
Mar-06-24 07:00AM
Mar-04-24 07:00AM
Feb-29-24 07:00AM
Feb-01-24 08:00AM
Jan-08-24 08:00AM
Jan-02-24 08:00AM
Dec-12-23 08:00AM
Dec-06-23 04:30PM
Nov-30-23 08:00AM
Nov-20-23 08:00AM
Nov-10-23 03:33PM
Nov-09-23 06:00AM
Nov-06-23 08:00AM
Oct-26-23 08:00AM
Sep-06-23 08:00AM
Aug-25-23 09:06AM
Aug-24-23 06:30AM
Aug-10-23 08:00AM
Jul-26-23 08:00AM
Jul-06-23 11:05AM
Jun-09-23 10:37AM
May-24-23 08:00AM
May-17-23 06:30AM
May-05-23 01:33PM
May-03-23 08:00AM
Apr-21-23 08:00AM
Apr-10-23 08:00AM
Apr-06-23 08:00AM
Apr-05-23 07:44PM
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.